Pages
Construction progresses on new £15m Belper Health Centre
https://dchs.nhs.uk/news/construction-progresses-new-15m-belper-health-centre
Plans approved for the development of Belper health services
https://dchs.nhs.uk/news/plans-approved-development-belper-health-services
Move to Defender AntiVirus
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/move-defender-antivirus
Update (21 June 2024): Ripley and Ilkeston Urgent Treatment Centres
https://dchs.nhs.uk/news/update-21-june-2024-ripley-and-ilkeston-urgent-treatment-centres
Files
DCHS - How to Complete a Saved Appraisal
DCHS - How to complete a saved appraisal
Vodafone_Storm Phone Escalation Process Flowchart.docx
Vodafone Storm Phone Escalation Process Flowchart
Bunion Silvers Bunionectomy (L27)
Bunion Silvers Bunionectomy. Podiatric Surgery patient information leaflet.
Nephrostomy Care and Flushing
Nephrostomy Care and Flushing
Derbyshire Skin Tone Tool (G254)
G254 - Derbyshire Skin Tone Tool
L314 - Why has my GP or nurse referred me to Diabetes Education
Why has my GP or nurse referred me to Diabetes Education
Guide to ordering 3rd Line Formulary Products and 3rd line and Non Formulary Request Form (G325)
Guide to ordering 3rd Line Formulary Products and 3rd line and Non Formulary Request Form
Disclosure Ref 202459 - MDO Victim Protocol.pdf
FOI Disclosure Ref 202459 relating to MDO Victim Protocol
Disclosure Ref 202478 - Junior Doctors Sick Leave.pdf
FOI Disclosure Ref 202478 regarding Junior Doctors Sick Leave
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010